Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer
A Randomized Controlled Feasibility Study Comparing a Multimodal Prehabilitation Protocol to Normal Care for Women Undergoing Neo-adjuvant Chemotherapy for Breast Cancer
1 other identifier
interventional
63
1 country
1
Brief Summary
To assess recruitment rate, attrition, compliance with weekly exercise, smoking cessation, and quality of life with a multimodal prehabilitation protocol for women with breast cancer undergoing neo-adjuvant chemotherapy for breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2 breast-cancer
Started Jul 2018
Typical duration for phase_2 breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2018
CompletedFirst Posted
Study publicly available on registry
June 20, 2018
CompletedStudy Start
First participant enrolled
July 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedApril 12, 2023
April 1, 2023
4.7 years
March 18, 2018
April 11, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Recruitment rate (percent reported by the research analyst )
What percent of eligible patients were successfuly recruitted in the study
18 month
Exercise compliance rate (percent reported by analysis of data)
number of exercise sessions per week and mean compliance rate (percent of the prescribed exercises within sessions)
18 month
Attrition rate (percent reported by data analysis)
what percent of the patients left the study?
18 month
Stress consultation compliance rate (percent reported by data analyst)
Percent of the patients that have satisfaction with counseling and use of education meterials that are provided to them.
18 months
Secondary Outcomes (5)
Quality of life (FACT-B questionnair)
18 months
Physical activity volume
6 months
Aerobic fitness (6 minute walk test)
6 months
Arm fitness (grip strength test)
6 months
Exercise tolerance ( FACT-An questionnair)
6 months
Study Arms (2)
Standard of Care
NO INTERVENTIONPatients will receive standard treatment without added intervention.
Intervention
EXPERIMENTALThese patients will receive standard treatment plus multimodal intervention (prehabilitation program) including : exercise, nutritional counseling, stress counseling, smoking cessation) before starting chemotherapy.
Interventions
stress counseling, exercise, nutritional counseling, smoking cessation counseling
Eligibility Criteria
You may qualify if:
- years and older, able to give consent, ECOG 0-1
You may not qualify if:
- pregnant, \> 80 years, medical contraindications to exercise. History of severe and persistent mental illness, cognitive impairment, recent suicide attempts or \>11 on "Hospital Anxiety and Depression Scale". If very active (\> 24) on the Godin-Shephard scale.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N3M5, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frances Wright, MD
Sunnybrook Health Sciences Centre
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 18, 2018
First Posted
June 20, 2018
Study Start
July 18, 2018
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share